Bradley attorney Whitt Steineker was quoted in Business Insurance on the impact that medical marijuana could have on opioid use. Medical marijuana and cannabinoid products are increasingly being promoted as a pain management alternative, but new studies have exposed doubts on political arguments that the drug will mitigate the effects of the opioid crisis. While many state legislatures have passed opioid restrictions and approved medical marijuana as a way to reduce the risk of opioid deaths, there’s no easy way to determine if it’s making a difference.
“We’re certainly seeing instances where people both on the health care side and the patient side believe there’s a chance their treatment would be better off with something like medical marijuana than something like opioids … I think that information is coming,” Steineker said, “but that’s where we don’t have the data yet.”
The complete article, “Questions raised about impact of medical marijuana on opioid use, deaths” first appeared in Business Insurance on July 10, 2019.